⌘+K

Pulse Explore Communities Researchers Journals

Browser extensionInstagram

Home Communities Explore

November 5, 2026Open Access

Additional file 1 of Combined casein kinase II and MAPK signalling inhibition as a therapeutic strategy for metastatic colorectal cancer

Mattia Marinucci Federico Donà Gina Faye Boot Cinzia Esposito Elenia Toccafondi Daniela Liberati Andrej Benjak L. Zaidi Melania Lazzari Giulia Milardi Karolina Guja-Jarosz Miriam Cieri Huiche Feng Mairene Coto‐Llerena Raoul A. Droeser Savas D. Soysal Otto Kollmar Guido Torzilli Antonino Spinelli Luigi Terracciano Charlotte K.Y. Ng Salvatore Piscuoglio

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Additional file 1. Supplementary Methods (including Supplementary References).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Marinucci et al. (2026) studied this question.

synapsesocial.com/papers/6af0111bc0da893a53643393 https://doi.org/10.6084/m9.figshare.34933556

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context:

1Additional file 3 of Combined casein kinase II and MAPK signalling inhibition as a therapeutic strategy for metastatic colorectal cancerOriginal Research · 2026
2Combined casein kinase II and MAPK signalling inhibition as a therapeutic strategy for metastatic colorectal cancerOriginal Research · 2026
3Supplementary File 2 from Vincristine Enhances the Efficacy of MEK Inhibitors in Preclinical Models of KRAS-mutant Colorectal Cancer2024
4Supplementary File 2 from Vincristine Enhances the Efficacy of MEK Inhibitors in Preclinical Models of KRAS-mutant Colorectal Cancer2024
5Supplementary Figures 1-4 and Tables 1-2 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis2024
6Supplementary Figures 1-4 and Tables 1-2 from Targeting CaMKK2 inhibits actin cytoskeletal assembly to suppress cancer metastasis2024
7Supplementary File 1 from Vincristine Enhances the Efficacy of MEK Inhibitors in Preclinical Models of KRAS-mutant Colorectal Cancer2024
8Supplementary File 1 from Vincristine Enhances the Efficacy of MEK Inhibitors in Preclinical Models of KRAS-mutant Colorectal Cancer2024

More from University of Bern

More from University Medical Center Utrecht

More from University of Basel

More from University Hospital of Basel

More from Oncode Institute

More from Humanitas University

More from IRCCS Humanitas Research Hospital

More from Kantonsspital Baselland